TetraLogic Pharmaceuticals Corporation
TLOG · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $3 | $7 |
| G&A Expenses | $1 | $2 | $3 | $3 |
| SG&A Expenses | $1 | $2 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $6 | $10 |
| Operating Income | -$9 | -$5 | -$9 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$10 | -$3 | -$2 | -$1 |
| Pre-Tax Income | -$11 | -$7 | -$11 | -$14 |
| Tax Expense | -$2 | $2 | $2 | $2 |
| Net Income | -$9 | -$8 | -$13 | -$16 |
| % Margin | – | – | – | – |
| EPS | -0.35 | -0.34 | -0.51 | -0.64 |
| % Growth | -2.9% | 33.3% | 20.3% | – |
| EPS Diluted | -0.35 | -0.34 | -0.51 | -0.64 |
| Weighted Avg Shares Out | 25 | 25 | 25 | 25 |
| Weighted Avg Shares Out Dil | 25 | 25 | 25 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $5 | $1 | $3 | $3 |
| EBITDA | -$9 | -$5 | -$9 | -$13 |
| % Margin | – | – | – | – |